poisar

Stocks · News reference

Lexaria Bioscience Enters New Pharmaceutical Agreement for DehydraTECH

Fiscal.ai

Lexaria Bioscience Corp. has signed an agreement with an unnamed pharmaceutical company to evaluate its proprietary DehydraTECH drug delivery technology with the partner's molecules.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading